Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-15-005296

VP of Clinical Development sold 22,149 shares at an average $8.88 ($196,664)

  • VP of Clinical Development acquired 30,388 shares (option exercise)
  • VP of Clinical Development gave up 8,342 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

GOLDBERG Y. PAUL · VP of Clinical Development

Table I: Non-derivative

21 lines
Date Transaction Shares Price Value Owned after D/I
2015-09-22 Exercise or conversion : show line 1 in the form +411 $5.22 $2,145 6,514 D
2015-09-22 Shares withheld for taxes : show line 2 in the form −198 $9.53 $1,887 6,316 D
2015-09-22 Exercise or conversion : show line 3 in the form +2,057 $3.21 $6,603 8,373 D
2015-09-22 Shares withheld for taxes : show line 4 in the form −610 $9.53 $5,813 7,763 D
2015-09-22 Exercise or conversion : show line 5 in the form +1,028 $3.77 $3,876 8,791 D
2015-09-22 Shares withheld for taxes : show line 6 in the form −305 $9.53 $2,907 8,486 D
2015-09-22 Exercise or conversion : show line 7 in the form +5,144 $3.07 $15,792 13,630 D
2015-09-22 Shares withheld for taxes : show line 8 in the form −1,525 $9.53 $14,533 12,105 D
Open-market sales · 22,149 sh · avg $8.88 · $196,664

Table II: Derivative

9 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-09-22 Exercise or conversion : show line 22 in the form Stock Option (Right to Buy) −411 $5.22 2015-12-31 411 0 D
2015-09-22 Exercise or conversion : show line 23 in the form Stock Option (Right to Buy) −2,057 $3.21 2016-12-31 2,057 0 D
2015-09-22 Exercise or conversion : show line 24 in the form Stock Option (Right to Buy) −1,028 $3.77 2017-12-31 1,028 0 D
2015-09-22 Exercise or conversion : show line 25 in the form Stock Option (Right to Buy) −5,144 $3.07 2018-12-31 5,144 0 D
2015-09-22 Exercise or conversion : show line 26 in the form Stock Option (Right to Buy) −6,172 $3.56 2019-12-31 6,172 0 D
2015-09-22 Exercise or conversion : show line 27 in the form Stock Option (Right to Buy) −3,703 $3.52 2020-07-01 3,703 0 D
2015-09-22 Exercise or conversion : show line 28 in the form Stock Option (Right to Buy) −3,115 $3.73 2020-12-01 3,115 1,000 D
2015-09-22 Exercise or conversion : show line 29 in the form Stock Option (Right to Buy) −7,973 $2.68 2022-12-31 7,973 4,372 D
2015-09-22 Exercise or conversion : show line 30 in the form Stock Option (Right to Buy) −785 $2.68 2022-12-31 785 243 D
Loading xslF345X03/gff4_goldberg092415.xml…